A recent genome-wide association study of childhood acute lymphoblastic leukemia (ALL) by Xu et al 1 has identified a novel susceptibility locus encompassing BMI1-PIP4K2A at chr10p12.31-12.2, bringing the number of known ALL risk loci to 5 (including ARID5B, IKZF1, CEBPE, and CDKN2A). [2] [3] [4] We sought to confirm and refine the BMI1-PIP4K2A association using single nucleotide polymorphism (SNP) array data from 297 Hispanic children with B-cell ALL (B-ALL) and 454 Hispanic control children from the California Childhood Leukemia Study. 5 Of 6 genome-wide significant BMI1-PIP4K2A SNPs reported by Xu et al, 1 their most strongly associated variant (rs7088318) was not significantly associated with B-ALL in our array data (P 5 .21). Intriguingly, the rs7088318 association approached significance when analyses were limited to hyperdiploid B-ALL (P 5 .08), the most common cytogenetic subgroup. We subsequently imputed genotypes using 1000 Genomes data (supplemental Methods) and saw a similar association pattern for their 5 remaining SNPs (supplemental Table 2 ), suggesting that this region may specifically confer risk for the hyperdiploid B-ALL subtype.
In total, 131 directly genotyped and 1371 imputed SNPs in the BMI1-PIP4K2A region were analyzed. Association tests were stratified into 3 groups: B-ALL, hyperdiploid B-ALL, and nonhyperdiploid B-ALL. No SNP was significantly associated with the risk for B-ALL in unstratified analyses (P . .01). A total of 8 array SNPs and 43 imputed SNPs were associated with hyperdiploid B-ALL risk (P , .01) ( Figure 1; supplemental Table 3 ). The array SNP most significantly associated with hyperdiploid B-ALL risk was rs10764338 (odds ratio [OR], 2.39; 95% confidence interval [CI], 1.48-3.87; P 5 3.5 3 10 24 ), but this SNP was not significantly associated with an increased risk for B-ALL in unstratified analyses (OR, 1.34; 95% CI, 0.97-1.85; P 5 .078).
One SNP (rs1750761) was associated with nonhyperdiploid ALL at P , .01 but had effects in opposite directions in analysis of nonhyperdiploid cases (OR, 0.55) vs analysis of hyperdiploid cases (OR, 1.62). In case-by-case comparisons, on comparison of hyperdiploid cases (N 5 97) with nonhyperdiploid cases (N 5 157), our top directly genotyped SNP from case-control analyses (rs10764338) was again significantly associated with an increased risk for hyperdiploid B-ALL (OR, 2.47; 95% CI, 1.42-4.29; P 5 9.8 3 10 24 ).
Although risk loci in ARID5B have been shown to confer a greater risk for hyperdiploid B-ALL vs other subtypes, 2,4 the risk loci in BMI1-PIP4K2A reported here are the first to be exclusively associated with this ALL subtype. Our results confirm that variation at chr10p12.31-12.2 confers a risk for childhood ALL and further indicates that these variants distinguish hyperdiploid B-ALL from other subtypes. Finemapping via SNP imputation refined the association peak to a ;35kb region in PIP4K2A, which includes a rare variant (rs142846483; minor allele frequency in controls 5 0.011) conferring an exceptionally high risk for hyperdiploid B-ALL among Hispanic children (OR, 15.15; 95% CI, 4.57-50.21 P 5 8.8 3 10 26 ).
The risk variants identified by Xu et al do not affect protein coding, although they found that the rs7088318 risk allele was associated with increased PIP4K2A messenger RNA expression. 1 Our most strongly associated SNPs were also intronic, suggesting that variants in PIP4K2A that confer risk for hyperdiploid B-ALL may be regulatory in nature, as has been observed in fine-mapping studies of other neoplastic diseases. 6, 7 
